|
223 Role
for pharmacists in National Programme for IT Pharmacists have
the opportunity to play a part in developing the multi-million pound
National Programme for IT for the NHS ...more
223 Society
offers contract monitoring service Primary care trusts and
local health boards have been offered a pharmacy contract monitoring
service by the Royal Pharmaceutical Society ...more
223 Inquiry
is opened into Shipman case pharmacist The pharmacist criticised during the Shipman inquiry for not noticing the GP’s abnormal prescribing of diamorphine appeared before the Royal Pharmaceutical Society’s Statutory Committee this week
...more
223 Society’s President to retire from Council Nicholas Wood, President of the Royal Pharmaceutical Society, is to step down from the presidency and retire from the Council at the Society’s annual general meeting in May
...more
224 NICE
publishes recommendations on lung cancer A clinical guideline
covering the diagnosis and treatment of lung cancer has been published
by the National Institute for Clinical Excellence ...more
224 Supplementary
prescribers to get CD access Pharmacists who are supplementary
prescribers will be able to prescribe Controlled Drugs from 14 March
...more
224 Radiopharmacists
set to share good practice on web A web portal for pharmacists
working in radiopharmacy is being developed through an initiative supported
by the European Union ...more
224 Pharmacy
project aims to reduce cancer risk A project in Glasgow that
aims to reduce cancer risk through the provision of information about
healthy living has been expanded ...more
224 NAO
cancer survey There has been encouraging progress made in
terms of patients’ experiences of cancer services since 2000,
according to a new report from the National Audit Office. However, communication
and symptom relief were highlighted as areas that could be improved upon ...more
224 European
cancer figures Nearly 2.9 million new cases of cancer are
diagnosed each year in Europe ...more
225 ETP and electronic
signatures widely accepted Plans to allow advanced electronic
signatures, without which the introduction of electronic prescribing
and prescription transfer would be pointless, have met with little opposition
...more
225 Government
should acknowledge that choice may be at odds with public health policy The
Government should acknowledge that its policy of promoting patient empowerment
and choice will sometimes be at odds with public health policy, according
to a professor of pharmacy practice ...more
225 Guild opposes
pensions plan Benefits for staff from proposed changes to
the NHS pension scheme are outweighed by the disadvantages, according
to the Guild of Healthcare Pharmacists ...more
225 Healthcare
Commission should challenge PCT pharmacy plans Primary care
trusts in England and local health boards in Wales should be asked by
the Healthcare Commission about their assessments of local pharmaceutical
needs and how they will be met through the new contract ...more
|
226 Pharmacist-led
heart clinics effective Cardiac clinics led by pharmacists
can improve the proportion of patients taking the recommended treatment
and reduce symptoms of heart failure. So say researchers who report results
from a pharmacist-led heart failure clinic in London ...more
226 Further insight
into SSRIs and suicide risk published Suicide risk associated
with use of selective serotonin reuptake inhibitors (SSRIs) has been
highlighted once more in a series of studies published in the BMJ ...more
226 Quetiapine
not suitable for treating agitation in dementia Quetiapine
does not improve symptoms of agitation in patients with dementia, according
to UK researchers. They also found that it increases cognitive decline
among these patients and conclude that it should not be used to control
symptoms ...more
227 MHRA to force
up medicine advertising standards All reviews of medicines
advertisements carried out by the Medicines and Healthcare products Regulatory
Agency will be published on the internet to try to force up standards
...more
227 How well
did we do, MHRA asks health professionals Views are being
sought by the Medicines and Healthcare products Regulatory Agency on
how well information on bringing British Approved Names for drugs (BANs)
in line with recommended International Non-proprietary names (rINNs)
was disseminated ...more
227 Call for
initiative to trigger investment in neglected diseases An
international treaty on a global programme of drug research should be
drawn up in an attempt to trigger investment in neglected disease, a
campaign group suggested this week ...more
227 ABPI code
should reflect pharmacists’ views The Association of
the British Pharmaceutical Industry has called on pharmacists to respond
to its consultation on the ABPI code of practice ...more
227 Staff rises
in NHS Scotland Figures released earlier this month show that
the number of staff working in NHS Scotland has increased over the past
year ...more
228 Regulatory
agencies reinforce COX-2 safety advice Recent advice on the
safety of selective cyclo-oxygenase-2 (COX-2) inhibitors issued by UK
and European drug regulators has been updated following a review of available
data ...more
228 MSD might
reconsider the future of Vioxx Merck Sharpe & Dohme has
indicated that the future of rofecoxib (Vioxx), the cyclo-oxygenase-2
(COX-2) inhibitor withdrawn from the market last year, is still open
to consideration ...more
228 Independent
board for FDA The US Food and Drug Administration has announced
plans to create an independent drug safety oversight board ...more
229 Repeat dispensing
system well received by GPs A pharmacist-managed repeat dispensing
system has been well received by GPs ...more
229 NPA launches
guide to new contract A step-by-step guide to changes being
brought in by the new pharmacy contract in England and Wales has been
produced by the National Pharmaceutical Association ...more
229 Strategic
tests published to help PCTs exploit new contract The National
Primary and Care Trust Development Programme has published a set of strategic
tests to help primary care trusts (PCTs) and strategic health authorities
in England make the most of the new community pharmacy contract ...more
229 GSK discount
announcement branded as unacceptable to pharmacies in Scotland GlaxoSmithKline’s
move to revise its discount terms for community pharmacies has been branded
as unacceptable arrogance in Scotland ...more
|
The
Pharmaceutical Journal